Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Deep Apple Therapeutics has announced a collaboration with Novo Nordisk to develop oral therapeutics for cardiometabolic diseases, potentially earning up to $812 million.
Outcomes4Me has acquired the Mika Health app from Fosanis GmbH to expand its AI-driven cancer care platform globally, announced in a press release.
AllSci has been awarded a grant from Montgomery County's Technology Innovation Fund to expand its AI platform for pharmaceutical and biotech research, as announced in a press release.
Novo Nordisk has partnered with DCAI to leverage the Gefion AI supercomputer for advancing drug discovery and healthcare innovation, as announced in a press release.
Lembas has emerged from stealth with a breakthrough in natural GLP-1 activation for weight management, announced in a press release. The company secured $3.6 million in funding to scale its AI-powered bioactive discovery platform.
Guy's and St Thomas' NHS Foundation Trust has launched the PATH initiative in collaboration with General Catalyst, NVIDIA, Hippocratic AI, and Sword Health to transform healthcare delivery using AI.
GLOBO Language Solutions has announced the rollout of its AI interpreter, GLOBO KAI, to 3,000 healthcare providers across the U.S., enhancing communication for limited English proficiency patients.
Evogene has completed its generative AI foundation model for small molecule design in collaboration with Google Cloud, enhancing capabilities in pharma and agriculture.
Southwest General Health Center has partnered with Notable to use AI for automating patient registration and care gap outreach, enhancing patient access and reducing staff workload.
Echosens and Boehringer Ingelheim have expanded their collaboration to enhance the diagnosis and care of metabolic dysfunction-associated steatohepatitis (MASH), focusing on early detection and non-invasive technologies.
Phare Bio has been selected to participate in the Google.org Accelerator, receiving funding and technical support to advance its AI-powered antibiotic discovery platform.
Axio BioPharma and Likarda have announced a strategic partnership to integrate AI-powered protein manufacturing with advanced drug delivery technologies, aiming to accelerate biologic drug development.
Planet Green Holdings Corp. has announced a new AI-driven initiative to support early mental health intervention for Canadian youth, focusing on anxiety and depression.
CorroHealth has made a strategic investment in SANTECHTURE, integrating its AI capabilities into SANTECHTURE's revenue cycle management products across the GCC region.
28bio has announced the Nexon neurotechnology platform, which integrates tissue engineering, neural interfacing, and AI to replicate complex neurological processes, according to a press release.
Researchers at the Else Kröner Fresenius Center for Digital Health have developed an AI agent to aid clinical decision-making in oncology, achieving a 91% accuracy rate in simulated cases.
Hemispherian AS has received a positive opinion from the EMA's Committee for Orphan Medicinal Products for its lead molecule, GLIX1, targeting glioma.
Research Grid's AI engine has successfully automated a three-year clinical trial at Queen Mary University of London, significantly reducing costs and errors, as announced in a press release.
DRUID AI has been recognized as the first Certified Software Provider for Healthcare AI in Central & Eastern Europe, Middle East, and Africa by Microsoft. This certification highlights DRUID AI's commitment to delivering secure and scalable AI solutions in the healthcare sector.
Cotiviti is hosting its annual client conference to address AI integration and interoperability in healthcare, focusing on cost reduction and efficiency improvements.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
